Senseonics Holdings Inc. ((SENS)) has held its Q2 earnings call. Read on for the main highlights of the call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Senseonics Holdings Inc. recently held its earnings call, revealing a generally positive sentiment despite some operational challenges. The company showcased significant growth in new patient starts and revenue, driven by strategic marketing investments and collaborations. While there are hurdles like decreased reorder volumes and the need for a reverse stock split, the overall outlook remains optimistic with growth indicators taking the forefront.
Strong New Patient Growth
The earnings call highlighted a remarkable 79% increase in new patient starts over the previous year and a 37% rise from Q1. This growth underscores the strong adoption of the Eversense 365 system, signaling a positive reception in the market.
Revenue Growth
Senseonics reported a 37% increase in net revenue, reaching $6.6 million in Q2 2025 compared to $4.9 million in the prior year. This growth was primarily driven by new insertions of the Eversense 365, reflecting the product’s growing market penetration.
Increased Marketing Investment
The company plans to significantly boost its marketing efforts, with joint direct-to-consumer advertising spending with Ascensia set to more than double to over $10 million in the next two quarters. This investment aims to enhance product awareness and drive further growth.
Collaborations and Partnerships
Senseonics is actively working on integrating its Eversense 365 with Sequel’s twiist pump, with availability expected later this year. This collaboration is part of the company’s strategy to expand its product ecosystem and enhance user experience.
Financial Strength
The company strengthened its financial position by raising approximately $78 million in gross proceeds during the second quarter, bringing its cash reserves to over $126 million. This financial boost provides a solid foundation for future growth initiatives.
Decreased Reorder Volume
A notable challenge discussed was the significant reduction in reorder volume for Q2 and Q3, attributed to the transition from a 6-month to a 1-year product cycle. This shift presents a temporary hurdle in maintaining consistent reorder levels.
Challenges in Retention Rate Data
The company acknowledged the lack of current data on retention rates for its 365-day product, relying instead on historical data from shorter-duration products. This gap in data presents a challenge in accurately assessing long-term product retention.
Need for Reverse Stock Split
To address stock price limitations and facilitate broader investor participation, Senseonics plans to seek shareholder approval for a reverse stock split. This move is aimed at enhancing the company’s market appeal and accessibility.
Forward-Looking Guidance
Looking ahead, Senseonics anticipates full-year 2025 global net revenue to be between $34 million and $38 million, with a significant portion expected in the fourth quarter. The company also announced plans for a pivotal IDE study for the Gemini system, targeting a U.S. commercial launch by the end of 2026. Additionally, efforts to expand the Eon Care network are underway to boost insertion capabilities.
In summary, Senseonics Holdings Inc.’s earnings call conveyed a positive sentiment, with strong growth indicators and strategic initiatives pointing towards a promising future. Despite some challenges, the company’s robust financial position and forward-looking plans underscore its commitment to sustained growth and market expansion.